MEGAN GITTINGS: Open Payments
NPI 1790877793 · HELENA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 51 payments from 12 companies in 2025. Trend: 2023 $759 · 2024 $648 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $305 |
| Janssen Biotech, Inc. | 6 | $269 |
| Novartis Pharmaceuticals Corporation | 14 | $258 |
| Regeneron Healthcare Solutions, Inc. | 4 | $70 |
| Incyte Corporation | 1 | $45 |
| Genentech USA, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Amgen Inc. | 2 | $32 |
| GENZYME CORPORATION | 2 | $31 |
| LEO Pharma Inc. | 1 | $21 |
Products named: SKYRIZI, TREMFYA, COSENTYX, DUPIXENT, OPZELURA, Xolair, Sotyktu, OTEZLA.
Industry payments across MT — which companies pay providers there.
